Kindeva Drug Delivery L.P. and Cambridge Healthcare Innovations Limited (CHI) have entered into a collaboration to develop and commercialize CHI’s αeolus dry-powder inhaler (DPI) platform technology.
Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, has launched as an independent company following its acquisition by Altaris Capital Partners in a transaction valued at $650 million.